{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "31", "geneName": "ACACA", "geneLongName": "ACETYL-COA CARBOXYLASE ALPHA", "entrezId": 31, "geneCategories": [{"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "4866b8ad-3c3e-4c04-802f-587f697212db", "name": "ENZYME"}], "interactions": []}, {"searchTerm": "31", "geneName": "ABCA11P", "geneLongName": "ATP BINDING CASSETTE SUBFAMILY A MEMBER 11, PSEUDOGENE", "entrezId": 79963, "geneCategories": [], "interactions": []}, {"searchTerm": "31", "geneName": "MAP2K1", "geneLongName": "MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1", "entrezId": 5604, "geneCategories": [{"id": "4c14ec3171544bd2b18b2f1a45e6c8f2", "name": "KINASE"}, {"id": "25da529a29714d34bc2e75f0856e1f63", "name": "SERINE THREONINE KINASE"}, {"id": "6c528ef943614261afc5e4f52a3c60ee", "name": "TYROSINE KINASE"}, {"id": "655bedfa9d71482796a5a34b87dfb297", "name": "DRUG RESISTANCE"}, {"id": "a57ab1984765420fb327fb129e99823f", "name": "NUCLEAR HORMONE RECEPTOR"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}, {"id": "0d157beb-fd17-404d-8755-3a81aa5ed704", "name": "CLINICALLY ACTIONABLE"}], "interactions": [{"interactionId": "76720263-0010-4d66-93ac-1f3ba1a14e24", "interactionTypes": [], "drugName": "CHEMBL546797", "drugConceptId": "chembl:CHEMBL546797", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "ff580cb4-44fc-4aee-a054-e8a61cd80670", "interactionTypes": [], "drugName": "VANDETANIB", "drugConceptId": "chembl:CHEMBL24828", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "e8247c23-debd-4b0e-886d-79a3f3ac3c56", "interactionTypes": [], "drugName": "PANITUMUMAB", "drugConceptId": "chembl:CHEMBL1201827", "sources": ["JAX-CKB", "CIViC"], "pmids": [26644315, 31227518], "score": 0.24}, {"interactionId": "10b800c9-4934-46bf-843f-e8de4a84a148", "interactionTypes": [], "drugName": "OMIPALISIB", "drugConceptId": "chembl:CHEMBL1236962", "sources": ["JAX-CKB"], "pmids": [22389471], "score": 0.13}, {"interactionId": "3cbf99c3-15a5-4499-b509-f720a80b4a3f", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "SELUMETINIB", "drugConceptId": "chembl:CHEMBL1614701", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "JAX-CKB", "ChemblInteractions", "COSMIC", "CIViC", "CancerCommons", "MyCancerGenomeClinicalTrial", "TTD"], "pmids": [22197931, 26324360, 17332304, 22327936, 25394791, 28029918, 18632602, 19915144, 26582713, 17699718, 23444215, 24448821, 27312529], "score": 0.81}, {"interactionId": "459c92a1-1afa-4ecb-a3b4-1a64bdbf507f", "interactionTypes": ["inhibitor"], "drugName": "TRAMETINIB DIMETHYL SULFOXIDE", "drugConceptId": "chembl:CHEMBL2105741", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "4cd49e14-9afc-4389-90c2-ed63cf6f07fe", "interactionTypes": [], "drugName": "VEMURAFENIB", "drugConceptId": "chembl:CHEMBL1229517", "sources": ["JAX-CKB", "DoCM", "CIViC"], "pmids": [22197931, 24265153, 21383288, 7651428, 18632602, 19915144, 23569304, 22389471, 25157968, 24448821, 27312529], "score": 0.6}, {"interactionId": "fe5eaf8f-9c75-46e7-8301-a15c2b5f390e", "interactionTypes": [], "drugName": "ARRY-300", "drugConceptId": "chembl:CHEMBL3545359", "sources": ["TdgClinicalTrial"], "pmids": [], "score": 0.41}, {"interactionId": "bb6798d8-c642-48e0-acb3-b054a1a6c58a", "interactionTypes": ["inhibitor"], "drugName": "AS-703988", "drugConceptId": "chembl:CHEMBL3545243", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "b4f3faa0-42b8-4b81-9bf7-17267ac75fb0", "interactionTypes": ["inhibitor"], "drugName": "BALAMAPIMOD", "drugConceptId": "chembl:CHEMBL2104954", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "c05728d8-bc4e-463b-9abf-fd81604a1661", "interactionTypes": [], "drugName": "CHEMBL406845", "drugConceptId": "chembl:CHEMBL406845", "sources": ["DTC"], "pmids": [], "score": 0.04}, {"interactionId": "60d163d3-9ef0-4ac9-8181-760edffc7356", "interactionTypes": ["inhibitor"], "drugName": "RG-7167", "drugConceptId": "chembl:CHEMBL3545383", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "50f2575e-95f8-4e3a-9b31-78f30af9b2e3", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "COBIMETINIB", "drugConceptId": "chembl:CHEMBL2146883", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "JAX-CKB", "ChemblInteractions", "CancerCommons", "MyCancerGenomeClinicalTrial", "OncoKB"], "pmids": [26566875, 26384788], "score": 0.97}, {"interactionId": "a10c3fca-82c3-438d-a357-14415fe37df7", "interactionTypes": ["antagonist", "inhibitor"], "drugName": "TRAMETINIB", "drugConceptId": "chembl:CHEMBL2103875", "sources": ["TALC", "MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "JAX-CKB", "CIViC", "MyCancerGenomeClinicalTrial", "OncoKB"], "pmids": [25370473, 26644315, 24265153, 25673644, 26566875, 26582713, 22389471, 25899310, 27312529, 24982505, 28179366, 23432625, 24265154], "score": 0.62}, {"interactionId": "9ca87b16-14c4-4151-ab52-ccd44ab93afc", "interactionTypes": [], "drugName": "CETUXIMAB", "drugConceptId": "chembl:CHEMBL1201577", "sources": ["JAX-CKB", "CIViC"], "pmids": [26644315, 27312529, 28179366], "score": 0.14}, {"interactionId": "65900cb7-5a5c-4640-9ace-60d8da2f941f", "interactionTypes": [], "drugName": "ILORASERTIB", "drugConceptId": "chembl:CHEMBL1980297", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "0eadca04-f3e5-4762-b7ed-f17fb7966cce", "interactionTypes": [], "drugName": "RG-1530", "drugConceptId": "chembl:CHEMBL1980391", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "520ca9be-0870-49de-9402-be8653572b1a", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "BINIMETINIB", "drugConceptId": "chembl:CHEMBL3187723", "sources": ["MyCancerGenome", "TdgClinicalTrial", "ClearityFoundationClinicalTrial", "ChemblInteractions", "CIViC", "MyCancerGenomeClinicalTrial"], "pmids": [31227518], "score": 0.48}, {"interactionId": "5f53e822-fdbe-4998-b803-63df49cc6262", "interactionTypes": [], "drugName": "CHEMBL1956073", "drugConceptId": "chembl:CHEMBL1956073", "sources": ["DTC"], "pmids": [20053779], "score": 1.24}, {"interactionId": "fcf9619d-8116-4f39-a9a3-42ebc68a0857", "interactionTypes": ["inhibitor"], "drugName": "COBIMETINIB FUMARATE", "drugConceptId": "chembl:CHEMBL2364607", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "31254ebc-e012-4b0e-80ff-8cbda786f7d4", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "REFAMETINIB", "drugConceptId": "chembl:CHEMBL1236682", "sources": ["MyCancerGenome", "JAX-CKB", "ChemblInteractions", "CancerCommons"], "pmids": [26582713], "score": 0.88}, {"interactionId": "18992289-2d56-4ee7-8f3a-030fd3865f29", "interactionTypes": ["inhibitor"], "drugName": "PIMASERTIB HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL4297676", "sources": ["CancerCommons"], "pmids": [], "score": 1.24}, {"interactionId": "22ee851a-d0bc-4db0-9d98-2acaf105e6cb", "interactionTypes": [], "drugName": "ALPELISIB", "drugConceptId": "chembl:CHEMBL2396661", "sources": ["JAX-CKB"], "pmids": [27312529], "score": 0.07}, {"interactionId": "be3740d2-9456-4fdd-af17-e0bbc8041f90", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "TAK-733", "drugConceptId": "chembl:CHEMBL1615025", "sources": ["MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions", "CancerCommons"], "pmids": [], "score": 0.62}, {"interactionId": "72e527cb-d2ce-4c7a-b493-da90a23c7926", "interactionTypes": ["inhibitor"], "drugName": "RG-7420", "drugConceptId": "chembl:CHEMBL3330650", "sources": ["MyCancerGenome", "ChemblInteractions"], "pmids": [], "score": 0.62}, {"interactionId": "630f27a6-29be-401d-9017-9593f4cd5b70", "interactionTypes": [], "drugName": "CENISERTIB", "drugConceptId": "chembl:CHEMBL1967878", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "a5832afe-8393-4b0d-bf58-27ac001b00cf", "interactionTypes": ["inhibitor"], "drugName": "RO-4987655", "drugConceptId": "chembl:CHEMBL1614766", "sources": ["ChemblInteractions", "CancerCommons"], "pmids": [], "score": 0.35}, {"interactionId": "a7bc56cc-82d1-40c8-9c14-0af7726c6a76", "interactionTypes": ["inhibitor"], "drugName": "WX-554", "drugConceptId": "chembl:CHEMBL3545145", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.35}, {"interactionId": "dc409757-b6af-4ea6-a356-97d9cb2abe0f", "interactionTypes": [], "drugName": "CERITINIB", "drugConceptId": "chembl:CHEMBL2403108", "sources": ["JAX-CKB"], "pmids": [25394791], "score": 0.22}, {"interactionId": "9b0b0907-46b0-4427-b566-8ff11c7d9d18", "interactionTypes": ["inhibitor"], "drugName": "PIMASERTIB", "drugConceptId": "chembl:CHEMBL2107832", "sources": ["TALC", "MyCancerGenome", "ClearityFoundationClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.55}, {"interactionId": "93735c19-f989-423d-8033-c89a13ecc6f2", "interactionTypes": ["allosteric modulator", "inhibitor"], "drugName": "CI-1040", "drugConceptId": "chembl:CHEMBL105442", "sources": ["MyCancerGenome", "JAX-CKB", "ChemblInteractions"], "pmids": [12370306, 19915144], "score": 0.27}, {"interactionId": "c3a01ccc-d842-480c-92a6-1c38e7fb4e9e", "interactionTypes": [], "drugName": "TOZASERTIB", "drugConceptId": "chembl:CHEMBL572878", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "96e996e6-e7d0-49ec-afda-041e7a715d24", "interactionTypes": [], "drugName": "CHEMBL202721", "drugConceptId": "chembl:CHEMBL202721", "sources": ["DTC"], "pmids": [], "score": 0.07}, {"interactionId": "b8f098a4-3d67-491c-bf00-6df769817b37", "interactionTypes": [], "drugName": "TAE-684", "drugConceptId": "chembl:CHEMBL509032", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "3587eb29-64d9-46bb-95be-e9f827f02ebc", "interactionTypes": ["inhibitor"], "drugName": "MEKINIST", "drugConceptId": "wikidata:Q29006164", "sources": ["CancerCommons"], "pmids": [], "score": 1.24}, {"interactionId": "202b6948-0a71-4786-b20a-af54e157278c", "interactionTypes": [], "drugName": "PD-0166285", "drugConceptId": "chembl:CHEMBL49120", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "26d046b9-8897-4609-ba14-b1dc464f8fa4", "interactionTypes": ["inhibitor"], "drugName": "E-6201", "drugConceptId": "chembl:CHEMBL1097999", "sources": ["JAX-CKB", "ChemblInteractions"], "pmids": [24448821], "score": 0.53}, {"interactionId": "76c01d7f-d7a2-4b05-b05f-b5a9cef161fb", "interactionTypes": ["inhibitor"], "drugName": "AZD-8330", "drugConceptId": "chembl:CHEMBL3182621", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 1.24}, {"interactionId": "34ace556-917e-4a3d-913c-1c0a7d53efd2", "interactionTypes": [], "drugName": "PLX-4720", "drugConceptId": "chembl:CHEMBL1230020", "sources": ["JAX-CKB"], "pmids": [21383288, 19915144], "score": 0.41}, {"interactionId": "782af4a4-8c0d-4cf9-b01c-9e60cdbc22e8", "interactionTypes": [], "drugName": "STAUROSPORINE", "drugConceptId": "chembl:CHEMBL388978", "sources": ["DTC"], "pmids": [], "score": 0.05}, {"interactionId": "0765ccca-f606-4fbb-b379-e52249486a30", "interactionTypes": [], "drugName": "CHEMBL379975", "drugConceptId": "chembl:CHEMBL379975", "sources": ["DTC"], "pmids": [], "score": 0.03}, {"interactionId": "5bd2da48-fd50-40ca-ab43-2d80ccbca9a3", "interactionTypes": [], "drugName": "SOTRASTAURIN", "drugConceptId": "chembl:CHEMBL565612", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "860573a9-0821-4bd8-896e-f9ec8607d6ee", "interactionTypes": [], "drugName": "JNJ-7706621", "drugConceptId": "chembl:CHEMBL191003", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "9b12f2b6-2ad0-445e-ab07-b4cae4d2f60a", "interactionTypes": ["inhibitor"], "drugName": "RG-7304", "drugConceptId": "chembl:CHEMBL3545081", "sources": ["DTC", "ChemblInteractions"], "pmids": [25766633], "score": 1.85}, {"interactionId": "66f606fd-bb8a-43a4-90f2-572bf160753b", "interactionTypes": [], "drugName": "DABRAFENIB", "drugConceptId": "chembl:CHEMBL2028663", "sources": ["JAX-CKB", "CIViC"], "pmids": [25370473, 24265153, 25673644, 22389471, 27312529, 24463458, 24265154], "score": 0.59}, {"interactionId": "6340487c-d425-4b0c-9a92-90539db767f1", "interactionTypes": [], "drugName": "ENCORAFENIB", "drugConceptId": "chembl:CHEMBL3301612", "sources": ["JAX-CKB"], "pmids": [27312529], "score": 0.31}, {"interactionId": "181a070d-97c4-4476-8de1-c29ad5ffe77c", "interactionTypes": ["inhibitor"], "drugName": "PD-0325901", "drugConceptId": "chembl:CHEMBL507361", "sources": ["DTC", "MyCancerGenome", "JAX-CKB", "ChemblInteractions"], "pmids": [23398453, 26267534, 25766633, 26582713, 10592235], "score": 1.01}, {"interactionId": "166cfb6e-c662-44ba-b829-7abba5d33ead", "interactionTypes": [], "drugName": "DASATINIB", "drugConceptId": "chembl:CHEMBL1421", "sources": ["DTC"], "pmids": [], "score": 0.02}, {"interactionId": "b685e7c3-96a6-4967-9512-50eb8f601c00", "interactionTypes": [], "drugName": "DOVITINIB", "drugConceptId": "chembl:CHEMBL522892", "sources": ["DTC"], "pmids": [], "score": 0.01}, {"interactionId": "b8d0c44f-c9e6-45f4-9696-0038e53cf178", "interactionTypes": [], "drugName": "DEL-22379", "drugConceptId": "wikidata:Q21044462", "sources": ["JAX-CKB"], "pmids": [26267534], "score": 0.62}]}], "unmatchedTerms": []}